The product type segment includes X-ray powder diffraction and single-crystal XRD. The X-ray powder diffraction is expected to be the largest segment in term of revenue with a value US$ 301.6 Mn in 2017, and is expected to continue its dominance during the forecast period.
The application segment which includes pharma, biotech, scientific research institutes, and others. The pharma segment is expected to be largest segment in term of revenue with a revenue US$ 158.6 Mn in 2017, and is expected to continue its dominance during the forecast period.
The X-ray diffractometer (XRD) market in Asia Pacific is estimated to account for major revenue share of US$ 116.9 Mn in 2017 and is expected to register a lucrative CAGR in next ten years. Market in North America is expected to account for second-highest revenue share. Increasing government initiatives for development of the X-ray diffractometer (XRD) sector in the US are expected to drive growth of the North America market.
Key players operating in the global X-ray diffractometer (XRD) market includes Bruker Corporation, Malvern Panalytical Ltd., Rigaku Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., Dandong Tongda Science & Technology Co., Ltd., and PERSEE ANALYTICS, INC.